Skip to content
★ Sign in to follow
Elutia Inc. logo

Elutia Inc. Stock: price and insider trades · United States

US·Mcap US$35.9MHealth Care

No insider purchase over the last 90 days. The latest, by NEELS GUIDO J, was filed 02 Feb 2026.

Elutia Inc.: what insiders have been doing

Elutia Inc. is a Health Care company. Its directors and officers file their transactions with SEC (Form 4). The last twelve months, up to 23 October 2026, brought 41 filings signed by 7 insiders.

Not one open-market sale was filed. On the buying side, 6 insiders reported 16 purchases totalling €200k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Those buying include 4 senior executives, 1 finance chief and 1 chief executive. Biggest ticket of the year: €62k, bought by Rakin Kevin and made public on 2 February 2026.

In all, 11 purchases were made within 30 days of a purchase by another insider of the company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The last insider purchase was made public on 2 February 2026, 279 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4.

Across the 3,167 companies tracked on its exchange, the median is 24 filings; at 41 filings, this issuer sits above that mark. Over the whole record (from 2020), the tally stands at 44 purchases and 2 sales. For the fiscal year to 31 December 2025, the annual 10-K puts net income at 53.4 m USD.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Insider Decl.
147
Thresholds
n/a
Buy Volume
€13M
44 ops. · all time
Sell Volume
€1,178
2 ops. · all time

Who traded when

BuySale
C. Randal Mills5 buys
Guido J. Neels3 buys
Matthew Ferguson3 buys
David Colpman2 buys
Kevin Rakin2 buys
Brigid Makes1 buy

+1 other insider

Since the insiders bought

  • Filed 02 Feb 2026 · 279 days ago · €17k
    +3.1%
    Entry US$0.98 · Close at T+90 US$1.01
  • Filed 02 Feb 2026 · 279 days ago · €62k
    +3.1%
    Entry US$0.98 · Close at T+90 US$1.01
  • Filed 18 Dec 2025 · 325 days ago · €1,302
    +79.2%
    Entry US$0.59 · Close at T+90 US$1.05

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Financial data

as of FY 2025

FY ended December 2025 · cache

US$0.81
Analyst consensus
1 analysts
1.00/5
US$5.00Target US$5.00(+517%)US$5.00
Income statement
RevenueUS$12.3M
Gross profitUS$6.6M54% margin
EBITDA-US$15.6M-127% margin
Net incomeUS$53.4M426.9% margin
Valuation
P/Book2.3x
Beta0.84
Balance sheet & cash
Market capUS$35.9M
Total debtUS$3.9M
Free Cash Flow-US$46.7M
Debt / Equity28%
Profitability & ownership
ROA-34.7%
% insiders3.6%
% institutions43.8%
Last declaration on 14 September 2026
Declarations147 total
  • ◇
    CHIEF FINANCIAL OFFICERExecutives
    0SEC
    12,500 sharesClass A Common StockSEC:0001304079-26-000010:0
  • ◆
    CHIEF FINANCIAL OFFICERExecutives
    3,589 USD27SEC
    4,486 shares@ US$0.800.0099% mcap1.5% of flowClass A Common StockSEC:0001304079-26-000010:1
  • ◇
    PRESIDENT AND CEOExecutives
    0SEC
    27,083 sharesClass A Common StockSEC:0001370939-26-000011:0
  • ◆
    PRESIDENT AND CEOExecutives
    7,774 USD40SEC
    9,718 shares@ US$0.800.021% mcap48.5% of flowClass A Common StockSEC:0001370939-26-000011:1
  • ◇
    CHIEF SCIENTIFIC OFFICERExecutives
    0SEC
    12,500 sharesClass A Common StockSEC:0001398249-26-000009:0
  • ◆
    CHIEF SCIENTIFIC OFFICERExecutives
    3,415 USD23SEC
    4,269 shares@ US$0.800.0094% mcap100.0% of flowClass A Common StockSEC:0001398249-26-000009:1
  • ◇
    PRESIDENT AND CEOExecutives
    0SEC
    22,473 sharesClass A Common StockSEC:0001370939-26-000008:0
  • ◆
    PRESIDENT AND CEOExecutives
    0SEC
    8,064 sharesClass A Common StockSEC:0001370939-26-000008:1
  • ◇
    DirectorExecutives
    0SEC
    6,250 sharesClass A Common StockSEC:0001222362-26-000006:0
  • ◆
    PRESIDENT AND CEOExecutives
    12,099 USD28SEC
    11,100 shares@ US$1.092.3% of flowClass A Common StockSEC:0001370939-26-000004:1
  • ◆
    CHIEF FINANCIAL OFFICERExecutives
    5,584 USD25SEC
    5,123 shares@ US$1.090.9% of flowClass A Common StockSEC:0001304079-26-000005:1
  • ◆
    CHIEF SCIENTIFIC OFFICERExecutives
    5,028 USD11SEC
    4,613 shares@ US$1.093.3% of flowClass A Common StockSEC:0001398249-26-000004:1
  • ◇
    CHIEF SCIENTIFIC OFFICERExecutives
    0SEC
    12,500 sharesClass A Common StockSEC:0001398249-26-000004:0
  • ◇
    PRESIDENT AND CEOExecutives
    0SEC
    27,084 sharesClass A Common StockSEC:0001370939-26-000004:0
  • ◇
    CHIEF FINANCIAL OFFICERExecutives
    0SEC
    12,500 sharesClass A Common StockSEC:0001304079-26-000005:0
  • ▲
    DirectorExecutives
    20,800 USD31SEC
    20,000 shares@ US$1.0456.8% of flowClass A Common StockSEC:0001222362-26-000004:0
    Canonical exit: 30 Apr 2026 (T+90)
  • ▲
    DirectorExecutives
    74,200 USD32SEC
    70,000 shares@ US$1.0673.7% of flowClass A Common StockSEC:0001104659-26-009295:0
    Canonical exit: 30 Apr 2026 (T+90)
  • ▲
    DirectorExecutives
    15,900 USD16SEC
    15,000 shares@ US$1.0630.2% of flowClass A Common StockSEC:0001222362-26-000002:1
    Canonical exit: 29 Apr 2026 (T+90)
  • ▲
    DirectorExecutives
    15,900 USD15SEC
    15,000 shares@ US$1.0643.2% of flowClass A Common StockSEC:0001222362-26-000002:0
    Canonical exit: 28 Apr 2026 (T+90)
  • ▲
    DirectorExecutives
    25,995 USD32SEC
    50,000 shares@ US$0.519926.3% of flowClass A Common StockSEC:0001104659-25-123259:0
    Canonical exit: 17 Mar 2026 (T+90)
  • ●
    DirectorExecutives
    0SEC
    4,505,941 sharesClass A Common StockSEC:0001104659-25-123182:0
  • ▲
    PRESIDENT AND CEOExecutives
    1,530 USD45SEC
    3,000 shares@ US$0.519.4% of flowClass A Common StockSEC:0001370939-25-000011:0
    Canonical exit: 17 Mar 2026 (T+90)
  • ▲
    DirectorExecutives
    6,375 USD35SEC
    12,500 shares@ US$0.5135.5% of flowClass A Common StockSEC:0001818776-25-000006:0
    Canonical exit: 17 Mar 2026 (T+90)
  • ▲
    DirectorExecutives
    13,000 USD37SEC
    25,000 shares@ US$0.52100.0% of flowClass A Common StockSEC:0001375927-25-000005:0
    Canonical exit: 17 Mar 2026 (T+90)
  • ▲
    CHIEF FINANCIAL OFFICERExecutives
    31,800 USD41SEC
    60,000 shares@ US$0.5315.8% of flowClass A Common StockSEC:0001304079-25-000008:0
    Canonical exit: 17 Mar 2026 (T+90)

25 of 147 declarations

About Elutia Inc.

Elutia Inc. is a company listed on the XNAS market. It specializes in the financial sector.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations